InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Melo John, Chairman & CEO. Director active across 1 company, notably AMYRIS, INC.. Cumulatively, 8 disclosures have been recorded. Split: 1 buy · 3 sells. Total volume traded: €2.7m. History available since 24 May 2021. The latest transaction was filed on 15 August 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
17,155 shares@ US$4.031.5% of flowCommon StockSEC:0001365916-22-000085:0
Ideal exit: 12 May 2023 (T+270)
54,091 shares@ US$2.122.6% of flowCommon StockSEC:0001365916-22-000074:0
95,115 shares@ US$15.528728.5% of flowCommon StockSEC:0000899243-21-028017
95,115 shares@ US$15.528729.7% of flowCommon StockSEC:0000899243-21-028017:0
73,572 shares@ US$14.2320.3% of flowCommon StockSEC:0001365916-21-000046:0
73,572 shares@ US$14.2319.5% of flowCommon StockSEC:0001365916-21-000046
149,365 shares0Common StockSEC:0001365916-21-000035:0
149,365 shares0Common StockSEC:0001365916-21-000035
8 of 8 declarations
About Melo John
John Melo is the President and CEO at Amyris, Inc. In this role, he is responsible for the strategic and operational direction of the company. Melo plays a key role in making decisions that influence the future direction of the organization. His expertise in biotechnology and management is essential for the success of the company.
